BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elsworthy RJ, Aldred S. Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors? J Alzheimers Dis 2019;69:651-61. [PMID: 31104017 DOI: 10.3233/JAD-180780] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition. Alz Res Therapy 2022;14:88. [DOI: 10.1186/s13195-022-01020-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu W, Zhao D, He Z, Hu Y, Zhu Y, Zhang L, Jin L, Guan L, Wang S. Synthesis and Biological Activity Evaluation of Benzothiazole-isoquinoline Derivatives.. [DOI: 10.21203/rs.3.rs-2004488/v1] [Reference Citation Analysis]
3 Elsworthy RJ, Dunleavy C, Whitham M, Aldred S. Exercise for the prevention of Alzheimer's disease: Multiple pathways to promote non-amyloidogenic AβPP processing. Aging and Health Research 2022;2:100093. [DOI: 10.1016/j.ahr.2022.100093] [Reference Citation Analysis]
4 Elsworthy RJ, Crowe JA, King MC, Dunleavy C, Fisher E, Ludlam A, Parri HR, Hill EJ, Aldred S. The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons. Transl Psychiatry 2022;12:285. [PMID: 35851379 DOI: 10.1038/s41398-022-02050-5] [Reference Citation Analysis]
5 Zhang C, Wang L, Xu Y, Huang Y, Huang J, Zhu J, Wang W, Li W, Sun A, Li X, Zhang H, Li J. Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression. European Journal of Medicinal Chemistry 2022;236:114347. [DOI: 10.1016/j.ejmech.2022.114347] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Otoni KM, Mormino KBNT, dos Santos SLF, Pereira MLL. Supportive Pharmacological Treatment. Pharmacological Treatment of Alzheimer's Disease 2022. [DOI: 10.1007/978-3-030-94383-7_6] [Reference Citation Analysis]
7 Zhao J, Jia Y, Zhao W, Chen H, Zhang X, Ngo FY, Luo D, Song Y, Lao L, Rong J. Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways. Oxid Med Cell Longev 2021;2021:7716201. [PMID: 34707778 DOI: 10.1155/2021/7716201] [Reference Citation Analysis]
8 Sarrouilhe D, Defamie N, Mesnil M. Is the Exposome Involved in Brain Disorders through the Serotoninergic System? Biomedicines 2021;9:1351. [PMID: 34680468 DOI: 10.3390/biomedicines9101351] [Reference Citation Analysis]
9 Correia AS, Cardoso A, Vale N. Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson's, and Alzheimer's Diseases, with a Connection with Serotonin. Int J Mol Sci 2021;22:8525. [PMID: 34445231 DOI: 10.3390/ijms22168525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Li R, Zhang Y, Zhuo Z, Wang Y, Jia Z, Sun M, Zhang Y, Li W, Duan Y, Yao Z, Weng H, Wei J, Liu Y, Xu J. Altered Cerebral Blood Flow in Alzheimer's Disease With Depression. Front Psychiatry 2021;12:687739. [PMID: 34305683 DOI: 10.3389/fpsyt.2021.687739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fabbretti E, Antognolli G, Tongiorgi E. Amyloid-β Impairs Dendritic Trafficking of Golgi-Like Organelles in the Early Phase Preceding Neurite Atrophy: Rescue by Mirtazapine. Front Mol Neurosci 2021;14:661728. [PMID: 34149353 DOI: 10.3389/fnmol.2021.661728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition.. [DOI: 10.1101/2021.03.28.437389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Reddy AP, Yin X, Sawant N, Reddy PH. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease. Hum Mol Genet 2021;30:847-64. [PMID: 33615359 DOI: 10.1093/hmg/ddab054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
14 Eftychios A, Nektarios S, Nikoleta G. Alzheimer Disease and Music-Therapy: An Interesting Therapeutic Challenge and Proposal. AAD 2021;10:1-18. [DOI: 10.4236/aad.2021.101001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Alcedo J, Prahlad V. Neuromodulators: an essential part of survival. J Neurogenet 2020;34:475-81. [PMID: 33170042 DOI: 10.1080/01677063.2020.1839066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Ali AM, Kunugi H. Royal Jelly as an Intelligent Anti-Aging Agent-A Focus on Cognitive Aging and Alzheimer's Disease: A Review. Antioxidants (Basel) 2020;9:E937. [PMID: 33003559 DOI: 10.3390/antiox9100937] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
17 Todd WD. Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer's Disease and Related Dementias. Front Neurosci 2020;14:910. [PMID: 33013301 DOI: 10.3389/fnins.2020.00910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
18 Huang J, Zuber V, Matthews PM, Elliott P, Tzoulaki J, Dehghan A. Sleep, major depressive disorder, and Alzheimer disease: A Mendelian randomization study. Neurology 2020;95:e1963-70. [PMID: 32817390 DOI: 10.1212/WNL.0000000000010463] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
19 Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease. Neuropharmacology 2020;174:108118. [PMID: 32380022 DOI: 10.1016/j.neuropharm.2020.108118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Cavalcante SFA, Simas ABC, Barcellos MC, de Oliveira VGM, Sousa RB, Cabral PAM, Kuča K, França TCC. Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention. Biomolecules 2020;10:E414. [PMID: 32155996 DOI: 10.3390/biom10030414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]